首页|新型查尔酮衍生物抗乳腺癌活性的3D-QSAR模型构建及分子设计

新型查尔酮衍生物抗乳腺癌活性的3D-QSAR模型构建及分子设计

扫码查看
为了获得较高抗乳腺癌活性的新型化合物,对18个新型查尔酮衍生物抗乳腺癌活性(pIC50)进行了三维定量构效关系(3D-QSAR)研究。其中14个化合物作为训练集用于构建3D-QSAR模型,其余化合物(含模板分子)作为测试集对所建模型进行验证。所建3D-QSAR模型的交叉验证系数R2CV为0。569,非交叉验证系数R2 为0。974,说明所建模型具有良好的稳定性和预测能力。该模型中立体场、静电场对pIC50的贡献分别为58。8%和41。2%,表明影响该类化合物抗肿瘤活性的主要因素是取代基的疏水性、空间位阻和电荷分布。通过对模型的分析,设计了 5个具有较高pIC50的新化合物,有待通过后续医学实验加以验证。
3D-QSAR model for anti-breast cancer activity of novel chalcones derivatives and their molecular design
In order to obtain novel compounds with high anti-breast cancer activity,three dimensional quantitative structure-activity relationships(3D-QSAR)between the structure of the anti-breast cancer activity(pIC50)of 18 novel chalcone derivatives is studied.The 3D-QSAR models are built using fourteen compounds in the training set,which are verified by the test set of other compounds(containing template molecule).The cross-validation coefficient R2CV of the 3D-QSAR model is 0.569,and the non-cross-validation coefficient R2 is 0.974.It indicates that the model has good stability and predictive ability.In this model,the contribution of stereoscopic field and electrostatic field to pIC50 are 58.8%and 41.2%,respectively,indicating that hydrophobicity,steric hindrance and charge distribution are the main factors affecting the pIC50.Through the analysis of the model,five new compounds with high pIC50 are designed,which need to be verified by future medical experiments.

novel chalcones compoundsanti-breast cancer activitiesthree dimensional quantitative structure-activity relationshipmolecular design

陈艳、冯惠、冯长君、堵锡华

展开 >

徐州工程学院材料与化学工程学院,江苏徐州 221018

新型查尔酮衍生物 抗乳腺癌活性 三维定量构效关系 分子设计

国家自然科学基金江苏省自然科学基金

21472071BK20171169

2024

南京理工大学学报(自然科学版)
南京理工大学

南京理工大学学报(自然科学版)

CSTPCD北大核心
影响因子:0.526
ISSN:1005-9830
年,卷(期):2024.48(2)
  • 7